T he Trump Administration has decided what the path to efficient government looks like: Cut costs, cut programs, cut jobs.

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...